Laura L. Parks
Laura Parks is a transformational business leader with a record of developing high-performance, market-focused teams. She led strategic commercial and operational initiatives as part of the executive leadership team at Patheon, a global biopharma contract development and manufacturing organization until its acquisition by Thermo Fisher Scientific.
Before that role, Dr. Parks served as president of DSM Pharmaceuticals, the $250M steriles and oral solid dosage finished dose contract manufacturing organization of DSM (merged with Patheon March 2014). She was promoted to that position after successfully leading the business unit’s marketing and sales team and functional excellence globally for DSM’s BioPharma business.
In the food ingredient industry, Dr. Parks was regional vice president, North America for Solae, a division of DuPont, where she led a $120 million business unit. She was vice president of sales for Solae for two years.
Dr. Parks earned a Ph.D. in Food Science from the University of Georgia and a Bachelor of Science from The Ohio State University. Dr. Parks currently serves on the Advisory Board of Lindy BioSciences in Durham, NC, and volunteers with Every Child Reading and a service dog training organization in Denver and the central Colorado mountains.